Wealth Enhancement Advisory Services’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
HWAM
BWCS
SFWA
PAM
SFA
AWM
FFA
MPWT
EWP
TWD
Wealth Enhancement Advisory Services's ALT Position: Q2 2026 in Review
Wealth Enhancement Advisory Services opened a new position in Altimmune (ALT) in Q2 2026: 25,989 shares worth $79.3K. The stake represents ﹤0.01% of the portfolio and ranks #3845 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in ALT as recently as Q2 2025.
Wealth Enhancement Advisory Services first reported a position in ALT in Q2 2024 and has held it in 6 quarters since. The position peaked at $118K in Q2 2025. 12 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Wealth Enhancement Advisory Services held 25,989 shares of Altimmune worth $79.3K as of Q2 2026.
- Altimmune was a new Wealth Enhancement Advisory Services position in Q2 2026.
- Altimmune made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3845 holding.
- Wealth Enhancement Advisory Services first reported a position in Altimmune in Q2 2024 and has held it in 6 quarters since.
- Wealth Enhancement Advisory Services's Altimmune position peaked at $118K in Q2 2025.
- 12 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.